Teachers Advisors LLC Has $1.35 Million Position in Teladoc, Inc. (TDOC)

Teachers Advisors LLC increased its stake in shares of Teladoc, Inc. (NYSE:TDOC) by 53.6% during the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 54,067 shares of the health services provider’s stock after buying an additional 18,862 shares during the period. Teachers Advisors LLC owned approximately 0.10% of Teladoc worth $1,352,000 at the end of the most recent quarter.

Other hedge funds also recently modified their holdings of the company. US Bancorp DE boosted its stake in shares of Teladoc by 10.3% in the first quarter. US Bancorp DE now owns 4,617 shares of the health services provider’s stock valued at $116,000 after buying an additional 433 shares during the last quarter. Jaffetilchin Investment Partners LLC boosted its stake in shares of Teladoc by 1.8% in the first quarter. Jaffetilchin Investment Partners LLC now owns 45,225 shares of the health services provider’s stock valued at $1,131,000 after buying an additional 814 shares during the last quarter. American International Group Inc. boosted its stake in shares of Teladoc by 22.2% in the first quarter. American International Group Inc. now owns 14,575 shares of the health services provider’s stock valued at $364,000 after buying an additional 2,644 shares during the last quarter. Great West Life Assurance Co. Can bought a new stake in shares of Teladoc during the first quarter valued at about $105,000. Finally, First Mercantile Trust Co. bought a new stake in shares of Teladoc during the first quarter valued at about $175,000. Institutional investors own 94.51% of the company’s stock.

Teladoc, Inc. (NYSE TDOC) traded down 0.33% during trading on Friday, reaching $29.85. The company had a trading volume of 658,907 shares. The company’s market capitalization is $1.69 billion. The firm’s 50 day moving average is $32.44 and its 200-day moving average is $28.23. Teladoc, Inc. has a 12 month low of $14.00 and a 12 month high of $36.90.

Teladoc (NYSE:TDOC) last posted its quarterly earnings results on Wednesday, August 2nd. The health services provider reported ($0.28) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.26) by $0.02. Teladoc had a negative return on equity of 19.88% and a negative net margin of 47.75%. The company had revenue of $44.60 million during the quarter, compared to analyst estimates of $44.39 million. During the same period last year, the company posted ($0.38) earnings per share. The company’s revenue was up 68.3% compared to the same quarter last year. On average, equities analysts expect that Teladoc, Inc. will post ($1.44) earnings per share for the current year.

Several equities analysts have recently commented on TDOC shares. BidaskClub raised Teladoc from a “sell” rating to a “hold” rating in a research note on Wednesday, August 9th. Chardan Capital upped their price target on Teladoc from $30.00 to $41.00 and gave the company a “buy” rating in a research note on Tuesday, June 20th. Canaccord Genuity reaffirmed a “buy” rating and issued a $42.00 price target (up previously from $34.00) on shares of Teladoc in a research note on Tuesday, June 20th. Craig Hallum lowered Teladoc from a “buy” rating to a “hold” rating and upped their price target for the company from $28.00 to $32.00 in a research note on Friday, May 12th. Finally, Oppenheimer Holdings, Inc. reaffirmed an “outperform” rating and issued a $40.00 price target (up previously from $27.00) on shares of Teladoc in a research note on Friday, June 9th. Two analysts have rated the stock with a sell rating, two have given a hold rating and ten have given a buy rating to the company. The stock currently has a consensus rating of “Buy” and an average target price of $35.55.

In other news, CEO Jason N. Gorevic sold 19,991 shares of the company’s stock in a transaction on Tuesday, June 6th. The shares were sold at an average price of $32.89, for a total value of $657,503.99. Following the transaction, the chief executive officer now directly owns 831,650 shares of the company’s stock, valued at $27,352,968.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Adam C. Vandervoort sold 53,806 shares of the company’s stock in a transaction on Monday, August 7th. The stock was sold at an average price of $30.92, for a total transaction of $1,663,681.52. Following the completion of the transaction, the insider now directly owns 33,008 shares in the company, valued at $1,020,607.36. The disclosure for this sale can be found here. Insiders sold 87,186 shares of company stock worth $2,761,550 over the last ninety days. 5.94% of the stock is currently owned by company insiders.

Teladoc Company Profile

Teladoc, Inc is a telehealth company. The Company offers telehealth platform, delivering on-demand healthcare anytime, anywhere, through mobile devices, the Internet, video and phone. The Company’s solution connects its Members, with its over 3,000 board certified physicians and behavioral health professionals treating a range of conditions and cases from acute diagnoses, such as upper respiratory infection, urinary tract infection and sinusitis to dermatological conditions, anxiety and smoking cessation.

Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc, Inc. (NYSE:TDOC).